26 June 2026
EDX Medical Group plc
("EDX Medical" or the "Company")
Results of General Meeting
CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, today announces the results of its general meeting, held at the Mezzanine Room, Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE on 26 June 2026 at 2.00 p.m.
Both resolutions put to members were passed on a poll. Resolution 1 was passed as an ordinary resolution and resolution 2 was passed as a special resolution.
The number of votes cast for and against each of the resolutions proposed, and the number of votes withheld were as follows:
|
Resolution |
Votes for |
% |
Votes against |
% |
Votes withheld |
|
Resolution 1 (Ordinary) To authorise the directors to allot equity securities in line with the limits set out in the Notice of General Meeting. |
201,208,426 |
94.41 |
11,913,139 |
5.59 |
0 |
|
Resolution 2 (Special) To authorise the directors, subject to resolution 1, to allot equity securities for cash as if section 561 of the Companies Act 2006 did not apply, with the limits set out in the Notice of General Meeting. |
201,216,561 |
94.41 |
11,904,843 |
5.59 |
161 |
As at 26 June 2026, there were 411,994,583 ordinary shares in issue with no shares held in treasury, resulting in total voting rights of 411,994,583. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.
The full text of each resolution is available in the Notice of General Meeting, published on our website at https://edxmedical.co.uk/documents/.
For enquiries, please contact:
|
EDX Medical Group plc |
|
|
Dr Mike Hudson (Chief Executive Officer) |
+44 (0)7812 345 301 |
|
Canaccord Genuity Limited (Nominated Adviser and Broker) |
|
|
Stuart Andrews |
+44 (0) 20 7523 8318 |
|
Media House International |
|
|
Ramsay Smith Gary McQueen |
+44 (0)7788 414856 + 44 (0)7834 694609 |
|
IFC Advisory (Investor Relations) |
|
|
Graham Herring Tim Metcalfe |
+44 (0) 203 934 6630 |